Ménière's disease

B-ENT

Volumn 3, Issue SUPPL. 6, 2007, Pages 11-20

  Van De Heyning, Paul H ^a,h   De Valck, C F J ^a   Boudewyns, A ^a   Cammaert, T ^b   Casteleyn, S ^c   Deggouj, N ^c   Gordts, F ^d   Forton, G ^a,e   Lefebvre, Ph ^f   Robillard, Th ^g  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Algemeen Ziekenhuis Sint Lucas Gent   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e Heilig Hart Ziekenhuis   (Belgium)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g Clinique & Maternite Sainte Elisabeth Namer   (Belgium)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Guidelines; Inner ear; M ni re's disease; Treatment

Indexed keywords

ACETAZOLAMIDE; ALPRAZOLAM; CINNARIZINE; CORTICOSTEROID; DIAZEPAM; DIHYDROBENZOPERIDOL; DIURETIC AGENT; DOMPERIDONE; GLUCOCORTICOID; HALOPERIDOL; MECLOZINE; PHENOTHIAZINE; SULPIRIDE;

ANXIETY DISORDER; AUDITORY THRESHOLD; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; ELECTROCOCHLEOGRAPHY; FOLLOW UP; HEARING LOSS; HEARING TEST; HUMAN; HYPERBARIC OXYGEN; LIFESTYLE MODIFICATION; MENIERE DISEASE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COUNSELING; PATIENT INFORMATION; PREVALENCE; QUALITY OF LIFE; REVIEW; VERTIGO; VESTIBULAR TEST; WORD RECOGNITION;

EID: 34948845018     PISSN: 1781782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. AAO-HNS. Committee on hearing and equilibrium. Guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg. 1995;113:181-185.
2. Havia M, Kentala E. Progression of symptoms of dizziness in Ménière's disease. Arch Otolaryngol Head Neck Surg. 2004;130:431-435.
3. Kinney SE, Sandridge SA, Newman CW. Long-term effects of Ménière's disease on hearing and quality of life. Am J Otol. 1997;18:67-73.
4. Da Costa SS, de Sousa LC, Piza MR. Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am. 2002;35:455-495.
5. Dunnebier EA, Segenhout JM, Wit HP, Albers FW. Two-phase endolymphatic hydrops: a new dynamic guinea pig model. Acta Otolaryngol. 1997;117:13-19.
6. Warmerdam TJ, Schroder FH, Wit HP, Albers FW. Perilymphatic and endolymphatic pressures during endolymphatic hydrops. Eur Arch Otorhinolaryngol. 2003;260:9-11.
7. Hallpike CS, Cairns H. Observations on the pathology of Ménière's syndrome. J Laryngol Otol. 1938;53:625-655.
8. Schuknecht HF, Gulya AJ. Endolymphatic hydrops. An overview and classification. Ann Otol Rhinol Laryngol Suppl. 1983;106:1-20.
9. Gacek RR, Gacek MR. Ménière's disease as a manifestation of vestibular ganglionitis. Am J Otolaryngol. 2001;22:241-250.
10. Yazawa Y, Kitahara M. Bilateral endolymphatic hydrops in Ménière's disease: review of temporal bone autopsies. Ann Otol Rhinol Laryngol. 1990;99:524-528.
11. Deggouj N, Gersdorff M, Crucifix N. Otological aspects of Ménière's syndrome. Acta Otorhinolaryngol Belg. 1989;43:579-591.
12. Xenellis JE, Linthicum FH Jr, Webster P, Lopez R. Basilar membrane displacement related to endolymphatic sac volume. Laryngoscope. 2004;114:1953-1959.
13. Fransen E, Verstreken M, Verhagen WI, et al. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet. 1999;8:1425-1429.
14. Kato BM, LaRouere MJ, Bojrab DI, Michaelides EM. Evaluating quality of life after endolymphatic sac surgery: the Ménière's disease outcomes questionnaire. Otol Neurotol. 2004;25:339-344.
15. Wuyts FL, Van de Heyning PH, Van Spaendonck MP, et al. Rate influences on tone burst summating potential amplitude in electrocochleography: clinical and experimental data. Hear Res. 2001;152:1-9.
16. Mateijsen DJ, Hengel PW, Kingma H, Oreel MA, Wit HP, Albers FW. Vertigo and electronystagmography in uni- and bilateral Ménière's disease. ORL J Otorhinolaryngol Relat Spec. 2001;63:341-348.
17. Fattori B, Nacci A, Casani A, Donati C, De Iaco G. Oxygen therapy in the long-term treatment of Ménière's disease [in Italian]. Acta Otorhinolaryngol Ital. 2001;21:1-9.
18. Claes J, Van de Heyning PH. A review of medical treatment for Ménière's disease. Acta Otolaryngol Suppl. 2000;544:34-39.
19. Pondugula SR; Sanneman JD, Wangemann P, Milhaud PG, Marcus DC. Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via sodium channel. Am J Physiol Renal Physiol. 2004;286:1127-1135.
20. Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment: a review. Otol Neurotol. 2004;25:1034-1039.
21. Boudewyns A, Wuyts F, Hoppenbrouwers M, et al. Meniett therapy: rescue treatment in severe drug-resistant Ménière's Disease? Acta Otolaryngol. 2005;125:1283-1289.
22. Franz P, Hamzavi J, Schneider B, Ehrenberger K. Do middle ear muscles trigger attacks of Ménière's disease? Acta Otolaryngol. 2003;123:133-137.
23. Borel L, Harlay F, Lopez C, Magnan J, Chays A, Lacour M. Walking performance of vestibular-defective patients before and after unilateral vestibular neurotomy. Behav Brain Res. 2004;150:191-200.
24. Hillman TA, Chen DA, Arriaga MA. Vestibular nerve section versus intratympanic gentamycin for Ménière's disease. Laryngoscope. 2004;114:216-222.
25. Kerr AG, Toner JG. A new approach to surgery for Ménière's disease: talking about surgery. Clin Otolaryngol Allied Sci. 1998;23:263-264.